Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma

This study is ongoing, but not recruiting participants.

Study NCT00004088 Information provided by National Cancer Institute (NCI)

First Received: December 10, 1999 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Additional conditions recognized in this trial

Multiple Myeloma
Neoplasms
Neoplasms, Plasma Cell

More general conditions related to this trial

Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Paraproteinemias
Vascular Diseases

Interventions listed in this trial

filgrastim
recombinant interferon alfa
busulfan
cyclophosphamide
melphalan
pamidronate disodium
thalidomide

Additional drug interventions recognized in this trial

Diphosphonates
Interferon Alfa-2a
Interferon Type I, Recombinant
Interferon-alpha
Interferons
Pamidronate

Sponsors listed in this trial

Beckman Research Institute
National Cancer Institute (NCI)

Back to top of Main Content